This study investigated whether the high expression of adhesion molecu
les on enriched preparations of circulating dendritic cells (DCs) was
an intrinsic property of the cells or whether it was a consequence of
the procedure used to isolate them from blood. Expression of the beta
1, beta 2 integrins (CD11/CD18 family) and other adhesion molecules on
DCs in whole blood was compared with that on isolated DCs. Dendritic
cells were identified by flow cytometry as leucocytes that were positi
ve for human leucocyte antigen (HLA)-DR, but negative for CD3, CD14, C
D16, CD19 and CD56. In contrast to a minority of DCs in whole blood, t
he majority of isolated DCs expressed the beta 2 integrins and there w
ere a greater number of cells bearing CD44, CD54 and some of the beta
1 integrins (notably CD49b, CD49d, CD49e and CD29). An increase in the
proportion of DCs bearing adhesion molecules was generally apparent a
t the isolation stage when mononuclear cells, which had been incubated
overnight, were centrifuged on a metrizamide gradient to enrich for c
ells of low density, Inclusion of an inhibitor of protein glycosylatio
n and exocytosis (brefeldin A) at all stages of separation partially p
revented an increase in the percentage of DCs bearing CD18, C29 and C5
4 whereas the inclusion of cycloheximide (an inhibitor of polypeptide
synthesis) interfered with increases in the percentage of cells bearin
g CD29 and CD54. Neither of these antagonists had an effect on the int
ensity of adhesion molecule expression. We suggest that some of the ad
hesion-dependent functions of isolated DCs are caused, in part, by an
upregulation of surface adhesion molecules induced by the enrichment p
rocedure.